Guardian Investor Services’s Regeneron Pharmaceuticals REGN Stock Holding History

Guardian Investor Services’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	$230K	Hold	510	–	–	0.18%	137
2014 Q4	$209K	Sell	510 -14	-3%	-$5.51K	0.17%	149
2014 Q3	$189K	Sell	524 -62	-11%	-$20.8K	0.15%	161
2014 Q2	$166K	Sell	586 -26	-4%	-$7.71K	0.13%	194
2014 Q1	$184K	Hold	612	–	–	0.14%	178
2013 Q4	$168K	Hold	612	–	–	0.13%	194
2013 Q3	$191K	Sell	612 -23	-4%	-$6.05K	0.16%	152
2013 Q2	$143K	Buy	+635	New	+$148K	0.12%	200

Other funds holding REGN

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Guardian Investor Services's REGN Position: Q1 2015 in Review

Guardian Investor Services held its Regeneron Pharmaceuticals (REGN) position steady in Q1 2015 at 510 shares worth $230K. The position accounts for 0.18% of the portfolio, ranked #137.

Guardian Investor Services first reported a position in REGN in Q2 2013 and has held it in 8 quarters since. 509 funds tracked by Wall St. Rank hold REGN as of Q1 2015.

Guardian Investor Services held 510 shares of Regeneron Pharmaceuticals worth $230K as of Q1 2015.
Guardian Investor Services left its Regeneron Pharmaceuticals share count unchanged in Q1 2015.
Regeneron Pharmaceuticals made up 0.18% of Guardian Investor Services's portfolio in Q1 2015, its #137 holding.
Guardian Investor Services first reported a position in Regeneron Pharmaceuticals in Q2 2013 and has held it in 8 quarters since.
509 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2015.

Based on Guardian Investor Services's 13F filing for Q1 2015, filed 5 May 2015.